학술논문
Mpox Knowledge, Attitudes, and Practices Among Persons Presenting for JYNNEOS Vaccination-District of Columbia, August to October 2022.
Document Type
Academic Journal
Author
Hassan R; From the Multinational Mpox Response.; Wondmeneh S; Epidemic Intelligence Service, National Center for State, Tribal, Local and Territorial Public Health Infrastructure and Workforce, Centers for Disease Control and Prevention, Atlanta, GA.; Gonzalez Jimenez N; From the Multinational Mpox Response.; Chapman K; Epidemic Intelligence Service, National Center for State, Tribal, Local and Territorial Public Health Infrastructure and Workforce, Centers for Disease Control and Prevention, Atlanta, GA.; Mangla A; DC Health, Washington, DC.; Ashley P; DC Health, Washington, DC.; Willut C; DC Health, Washington, DC.; Lee M; DC Health, Washington, DC.; Rhodes T; DC Health, Washington, DC.; Gillani S; DC Health, Washington, DC.; Copen C; From the Multinational Mpox Response.; Jackson DA; From the Multinational Mpox Response.; Waltenburg M; From the Multinational Mpox Response.; Delaney KP; From the Multinational Mpox Response.; Miles G; From the Multinational Mpox Response.; Agnew-Brune C; From the Multinational Mpox Response.; Oakley LP; From the Multinational Mpox Response.
Source
Publisher: J B Lippincott Country of Publication: United States NLM ID: 7705941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-4521 (Electronic) Linking ISSN: 01485717 NLM ISO Abbreviation: Sex Transm Dis Subsets: MEDLINE
Subject
Language
English
Abstract
Background: More than 30,000 mpox cases have been confirmed in the United States since May 2022. Mpox cases have disproportionally occurred among adult gay, bisexual, and other men who have sex with men; transgender persons; and Black and Hispanic/Latino persons. We examined knowledge, attitudes, and practices regarding mpox vaccination among adults presenting for vaccination to inform prevention efforts.
Methods: We collected mixed-methods data from a convenience sample of adults presenting for JYNNEOS vaccination at 3 DC Health mpox vaccine clinics during August-October 2022. Survey and interview topics included knowledge about mpox symptoms and vaccine protection, beliefs about vaccine access, and trusted sources of information.
Results: In total, 352 participants completed self-administered surveys and 62 participants completed an in-depth interview. Three main themes emerged from survey and interview data. First, most participants had a general understanding about mpox, but gaps remained in comprehensive understanding about mpox symptoms, modes of transmission, vaccine protection, personal risk, and vaccine dosing strategies. Second, participants had high trust in public health agencies. Third, participants wanted more equitable and less stigmatizing access to mpox vaccine services.
Conclusions: Nonstigmatizing, inclusive, and clear communication from trusted sources, including public health agencies, is needed to address mpox knowledge gaps and increase vaccine access and uptake in affected communities. Mpox outreach efforts should continue innovative approaches, including person-level risk assessment tools, to address community needs.
Competing Interests: Conflict of Interest and Sources of Funding: None declared.
(Copyright © 2023 American Sexually Transmitted Diseases Association. All rights reserved.)
Methods: We collected mixed-methods data from a convenience sample of adults presenting for JYNNEOS vaccination at 3 DC Health mpox vaccine clinics during August-October 2022. Survey and interview topics included knowledge about mpox symptoms and vaccine protection, beliefs about vaccine access, and trusted sources of information.
Results: In total, 352 participants completed self-administered surveys and 62 participants completed an in-depth interview. Three main themes emerged from survey and interview data. First, most participants had a general understanding about mpox, but gaps remained in comprehensive understanding about mpox symptoms, modes of transmission, vaccine protection, personal risk, and vaccine dosing strategies. Second, participants had high trust in public health agencies. Third, participants wanted more equitable and less stigmatizing access to mpox vaccine services.
Conclusions: Nonstigmatizing, inclusive, and clear communication from trusted sources, including public health agencies, is needed to address mpox knowledge gaps and increase vaccine access and uptake in affected communities. Mpox outreach efforts should continue innovative approaches, including person-level risk assessment tools, to address community needs.
Competing Interests: Conflict of Interest and Sources of Funding: None declared.
(Copyright © 2023 American Sexually Transmitted Diseases Association. All rights reserved.)